Shigeo Koido Selected Research

Neoplasm Antigens (Tumor Antigens)

9/2019	In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.
9/2011	Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response.
1/2009	Cancer immunotherapy by fusions of dendritic cells and tumor cells.
9/2008	Cell fusion: from hybridoma to dendritic cell-based vaccine.
11/2005	Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
12/2004	Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeo Koido Research Topics

Disease

66	Neoplasms (Cancer) 02/2024 - 02/2003
21	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 06/2010
18	Wilms Tumor (Wilm's Tumor) 02/2024 - 09/2013
8	Adenocarcinoma 02/2024 - 10/2015
7	Ulcerative Colitis 02/2023 - 05/2013
6	Breast Neoplasms (Breast Cancer) 07/2015 - 02/2003
6	Carcinoma (Carcinomatosis) 03/2013 - 02/2003
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2023 - 10/2010
5	Hypersensitivity (Allergy) 01/2019 - 02/2014
5	Colorectal Neoplasms (Colorectal Cancer) 05/2016 - 11/2005
4	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2012
3	Crohn Disease (Crohn's Disease) 01/2019 - 05/2013
2	Constipation 01/2023 - 01/2019
2	Necrosis 01/2022 - 01/2015
2	Fever (Fevers) 01/2021 - 09/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2014 - 07/2013
2	Ovarian Neoplasms (Ovarian Cancer) 10/2011 - 01/2010
2	Residual Neoplasm 01/2009 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 09/2008 - 08/2007
1	Adenocarcinoma of Lung 02/2024
1	Lung Neoplasms (Lung Cancer) 02/2024
1	Aneurysm (Aneurysms) 01/2023
1	Vascular Diseases (Vascular Disease) 01/2023
1	Cholangitis 10/2022
1	Granuloma 01/2022
1	Infections 01/2019
1	Human Influenza (Influenza) 01/2019
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019
1	Dysbiosis 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019

Drug/Important Bio-Agent (IBA)

35	AntigensIBA 10/2022 - 12/2004
29	VaccinesIBA 02/2024 - 02/2003
21	Cancer VaccinesIBA 01/2019 - 02/2003
17	Peptides (Polypeptides)IBA 10/2020 - 01/2010
10	Gemcitabine FDA Link 01/2018 - 01/2011
6	Neoplasm Antigens (Tumor Antigens)IBA 09/2019 - 12/2004
6	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2013
6	PicibanilIBA 01/2018 - 01/2007
5	Mucin-1 (CA 15-3 Antigen)IBA 02/2024 - 02/2003
4	Interleukin-12 (IL 12)IBA 02/2016 - 04/2002
3	HLA-A Antigens (HLA-A)IBA 10/2022 - 03/2007
3	AcidsIBA 01/2022 - 05/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 10/2020 - 05/2013
3	Messenger RNA (mRNA)IBA 07/2019 - 09/2011
3	Combined VaccinesIBA 01/2018 - 07/2013
3	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 06/2010
3	EpitopesIBA 01/2015 - 08/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2014 - 06/2010
3	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2013 - 01/2013
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2013 - 01/2010
3	HLA-A*02:01 antigenIBA 05/2013 - 12/2004
3	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2012 - 02/2003
3	Carcinoembryonic AntigenIBA 09/2008 - 11/2005
2	Therapeutic UsesIBA 02/2024 - 01/2023
2	Azathioprine (Imuran)FDA LinkGeneric 07/2023 - 01/2015
2	Mesalamine (Mesalazine)FDA LinkGeneric 02/2023 - 08/2022
2	16S Ribosomal RNAIBA 01/2023 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 10/2022 - 10/2015
2	Metronidazole (Metric)FDA LinkGeneric 01/2021 - 01/2014
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2021 - 01/2014
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2021 - 01/2014
2	Small Interfering RNA (siRNA)IBA 07/2019 - 01/2015
2	WT1 ProteinsIBA 08/2018 - 02/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 05/2013
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 06/2017 - 01/2015
2	CarbohydratesIBA 06/2017 - 01/2015
2	SulfotransferasesIBA 06/2017 - 01/2015
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2016 - 02/2013
2	InterleukinsIBA 10/2015 - 01/2014
2	Ado-Trastuzumab EmtansineIBA 10/2015 - 07/2015
2	MucinsIBA 10/2015 - 06/2003
2	Protein Subunit VaccinesIBA 12/2013 - 05/2013
2	Ethanol (Ethyl Alcohol)IBA 08/2013 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 06/2010
2	Penicillins (Penicillin)FDA Link 01/2013 - 01/2007
1	Anaplastic Lymphoma KinaseIBA 02/2024
1	Tyrosine Kinase InhibitorsIBA 02/2024
1	B7-H1 AntigenIBA 02/2024
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2024
1	ErbB Receptors (EGF Receptor)IBA 02/2024
1	Sulfalene (Longum)IBA 01/2023
1	N 30IBA 10/2022
1	Mucin-3IBA 10/2022
1	Epithelial Cell Adhesion MoleculeIBA 10/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2019
1	OligonucleotidesIBA 07/2019
1	MicroRNAs (MicroRNA)IBA 07/2019
1	PrebioticsIBA 01/2019
1	25-hydroxyvitamin DIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 11/2020 - 01/2011
17	Immunotherapy 09/2019 - 06/2003
14	Therapeutics 02/2024 - 06/2010
2	Aftercare (After-Treatment) 02/2024 - 02/2014
2	Immunomodulation 01/2018 - 09/2014
2	Radiotherapy 07/2013 - 07/2013
1	Fecal Microbiota Transplantation 01/2019